Nature Communications (Sep 2022)

Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study

  • Julia Stowe,
  • Nick Andrews,
  • Freja Kirsebom,
  • Mary Ramsay,
  • Jamie Lopez Bernal

DOI
https://doi.org/10.1038/s41467-022-33378-7
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 8

Abstract

Read online

SARS-CoV-2 variants of concern have been associated with reduced vaccine effectiveness, even after a booster dose. In this study, authors aim to estimate vaccine effectiveness against hospitalisation with the Omicron and Delta variants, using different definitions of hospitalisation in secondary care data.